In a review by McGhee et al. (2014) which looked at disease progression markers in AD, the prognostic value of CSF-total tau was small and seemed hard to capture, even in studies including 100 (Zetterberg et al., 2006) and 274 (Andreasen et al., 1999) patients. Here, MAPT is linked to Alzheimer disease.